[1] REYNOLDS D, KOLLEF M.The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update[J]. Drugs, 2021, 81(18): 2117-2131. [2] SANDO E, SUZUKI M, ISHIDA M, et al.Definitive and indeterminate Pseudomonas aeruginosa infection in adults with community-acquired pneumonia: a prospective observational study[J]. Ann Am Thorac Soc, 2021, 18(9): 1475-1481. [3] XIAO ZH, HOU PG, GUO L, et al.Bacterial drug resistance and changes of lower respiratory tract flora in patients with pseudomonas aeruginosa pneumonia[J]. China Clinical Practical Medicine(中国临床实用医学), 2020, (1): 19-22. [4] PENG ZH, ZHANG N, ZHANG HT, et al.Clinical distribution and drug resistance of carbapenem-insensitive Pseudomonas aeruginosa in a tertiary hospital from 2016 to 2018[J]. Chinese Journal of Antibiotics(中国抗生素杂志), 2022, 47(6): 596-601. [5] NOLAN C, BEHRENDS V.Sub-inhibitory antibiotic exposure and virulence in Pseudomonas aeruginosa[J]. Antibiotics (Basel), 2021, 10(11): 1393 [6] MARTENS E, DEMAIN AL.The antibiotic resistance crisis, with a focus on the United States[J]. J Antibiot (Tokyo), 2017, 70(5): 520-526. [7] XIA JING, QU XK, ZHANG HB, et al.Clinical observation of Shufeng Jiedu capsule combined with piperacillin tazobactam in the treatment of acute exacerbation of chronic obstructive pulmonary disease complicated with community-acquired pneumonia[J]. Emergencies in Chinese Medicine(中国中医急症), 2021, 30(7): 1233-1236. [8] GUO GH, SONG B, XIAO JH, et al.Clinical observation of Shufeng Jiedu capsule combined with cefazolin in the treatment of community-acquired pneumonia[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2020, 35(12): 6437-6440. [9] LI DW, WU J, LI L, et al.Observation on the efficacy of Shufeng Jiedu capsule combined with antibiotics in the treatment of community-acquired pneumonia[J]. Chinese Community Doctors(中国社区医师), 2020, 36(33): 114-115. [10] YIN ZP, SUN S.Clinical study of Shufeng Jiedu capsule combined with levofloxacin in the treatment of acute exacerbation of chronic bronchitis[J]. Drugs & Clinical(现代药物与临床), 2018, 33(11): 2880-2883. [11] LI W, GUO SS, CUI X, et al.Effects of Xiaoerganning granules on serum MCP-1 content and ERK and NF-KB signaling pathways in lung tissue of mice after influenza virus infection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017, 14(2): 65-68. [12] BAO YY, GAO YJ, CUI XL.Effect of Shufeng Jiedu capsules as a broad-spectrum antibacterial[J]. BioSci Trends, 2016, 10(1): 74-78. [13] SHI YJG, BAO YY, GUO SNSN, Et al. Synergistic effect of Pudilan Xiaoyan oral liquid combined with amoxicillin on Streptococcus pneumoniae infection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(4): 346-351. [14] GUO SS, BAO L, LI W, et al.Effects of Jinlan Granules on the model of acute pharyngitis induced by bacterial infection in juvenile animals[J]. World Journal of Traditional Chinese and Western Medicine(世界中西医结杂志), 2018, 13(11): 1489-1492. [15] SUN J, GAO YJ, SHI YJ, et al.Study on the effect of Qingre Sanjie capsule on the model of bacterial respiratory tract infection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(8): 449-454. [16] FENG YW, LIU LM, ZHANG JJ.Analysis and prospect of traditional Chinese medicine treatment of infectious diseases[J]. Journal of Zhejiang Chinese Medicine University(浙江中医药大学学报), 2018, 42(7): 590-594. [17] HAN F, XING RH, CHEN LQ, et al.Research progress of anti-drug resistance in traditional Chinese medicine[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2016, 41(5): 813-817. [18] ZHANG TJ, ZH Q, LI XY, et al.Systematic research of secondary development of Shufeng Jiedu Capsule[J]. Chinese Herbal Medicines(中草药), 2019, 50(15): 3517-3525. [19] QIAN YQ, WU FH, LIU G, et al.Advances in clinical application of Shufeng Jiedu Capsules[J]. Shizhen Journal of traditional Chinese medicine research(时珍国医国药), 2018, 29(8): 1956-1958. [20] LI YQ.Overview of clinical application of Shufeng Jiedu capsules[J]. Journal of Emergency in Traditional Chinese Medicine(中国中医急症), 2017, 26(4): 652-655, 658. [21] HU JJ, HUANG FL.Efficacy evaluation of Shufeng Jiedu capsule combined with levofloxacin in the treatment of bronchiectasis complicated with pulmonary infection during acute exacerbation[J]. Beijing Journal of Traditional Chinese Medicine(北京中医药), 2015, 34(12): 979-981. [22] ZHANG SH, LI T, FAN YH, et al.Clinical observation of Shufeng Jiedu capsule combined with levofloxacin in the treatment of community-acquired pneumonia without increased peripheral blood leukocytes[J]. Beijing Medical Journal(北京医学), 2016, 38(10) : 1128-1129,1132. |